Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

NCT00625937 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: cisplatin
DRUG: docetaxel
DRUG: tegafur-gimeracil-oteracil potassium
RADIATION: radiation therapy

Sponsor

Yonsei University